Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The EMBO Journal|June 14, 2003
The thyroid hormone receptor antagonizes CREB-mediated transcriptionMarinela Méndez-Pertuz, Aurora Sánchez-Pacheco, Ana ArandaEndocrinology|October 13, 2009
Residues K128, 132, and 134 in the thyroid hormone receptor-alpha are essential for receptor acetylation and activityAurora Sánchez-Pacheco, Olaia Martínez-Iglesias, Marinela Méndez-Pertuz, et al.Chemical Biology & Drug Design|August 31, 2019
Screening protocol for the identification of modulators by immunofluorescent cell-based assayJavier Klett, Elena Gómez-Casero, Marinela Méndez-Pertuz, et al.Drugs in R&D|May 24, 2026
A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine TumorsJavier Molina-Cerrillo, Arantzazu Sierra-Ramirez, José L López-Aceituno, et al.Nature Communications|November 4, 2017
Modulation of telomere protection by the PI3K/AKT pathwayMarinela Méndez-Pertuz, Paula Martínez, Carmen Blanco-Aparicio, et al.Journal of the National Cancer Institute|October 31, 2012
Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological studyAndré F S Amaral, Marinela Méndez-Pertuz, Alberto Muñoz, et al.EMBO Molecular Medicine|May 15, 2015
Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damageMaría García-Beccaria, Paula Martínez, Marinela Méndez-Pertuz, et al.Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumorsChristian Hafner, Agustí Toll, Alejandro Fernández-Casado, et al.BMC Genomics|May 23, 2015
The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studiesJulie Earl, Daniel Rico, Enrique Carrillo-de-Santa-Pau, et al.Pageof 1